4-Methylpiperidine-4-carboxamide hydrochloride

Catalog No.: 
ACFWDZ598
CAS No.: 
1257301-28-2
Molecular Formula: 
C7H15ClN2O
Molecular Weight: 
178.66
4-Methylpiperidine-4-carboxamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$64.00In stockInquiry
250mg97%$78.00In stockIn stock
1g97%$187.00In stockIn stock
5g97%$615.00In stockIn stock
25g97%$2925.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methylpiperidine-4-carboxamide hydrochloride
IUPAC Name4-methylpiperidine-4-carboxamide hydrochloride
MDL No.MFCD21605970
Molecular FormulaC7H15ClN2O
Molecular Weight178.66
SMILESO=C(C1(C)CCNCC1)N.[H]Cl
InChI KeyHYAIBMPHCZJEDI-UHFFFAOYSA-N
Synonym4-Methyl-4-piperidinecarboxamide hydrochloride;4-Methylpiperidine-4-carboxamide hydrochloride;4-Piperidinecarboxamide, 4-methyl-, hydrochloride (1:1);4-Methyl-piperidine-4-carboxylic acid aMide hydrochloride
CAS No.1257301-28-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P261-P264-P272-P280-P302+P352-P305+P351+P338-P333+P313-P337+P313-P363-P501

Synthetic Route by SureRoute

1. ACFWDZ598 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFWDZ598 route product structure diagram
    ACFWDZ5981257301-28-2In Stock
Inquiry

2. ACFWDZ598 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFWDZ598 route product structure diagram
    ACFWDZ5981257301-28-2In Stock
Inquiry

3. ACFWDZ598 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFWDZ598 route product structure diagram
    ACFWDZ5981257301-28-2In Stock
Inquiry

Comments (0)